Table 6.

Number of Patients Receiving Indicated Treatment for Antiosteoporosis Medication

Criteria for Treatment	Group A (n = 90)	Group B (n = 87)	P Value	Total (n = 177)
Previous low-energy fracture after age 50 yr	5	2	0.17	7
BMD T-score < −2.5	2	1	0.47	3
T-score −1 to −2.5 with FRAX hip > 3% or MOF > 20%	6	2	0.09	8
Multiple criteria met	3	4	0.56	7
Total	16	11	0.26	27 (15%)
Received treatment	5 (31%)	8 (73%)	<0.001	13 (48%)

BMD = bone mineral density, FRAX = fracture risk assessment tool, MOF = major osteoporotic fracture